Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
Holding XVIPF?
Track your performance easily

Xvivo Perfusion AB (XVIPF) Income Statement

5 Followers

Xvivo Perfusion AB Income Statement

Last quarter (Q1 2023), Xvivo Perfusion AB's total revenue was kr140.62M, an increase of 51.76% from the same quarter last year. In Q1, Xvivo Perfusion AB's net income was kr14.18M. See Xvivo Perfusion AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 463.25Mkr 415.29Mkr 258.39Mkr 179.86Mkr 220.84Mkr 187.87M
Cost of Revenue
kr 126.70Mkr 118.34Mkr 70.11Mkr 50.13Mkr 58.02Mkr 51.91M
Gross Profit
kr 336.55Mkr 296.96Mkr 188.28Mkr 129.73Mkr 162.81Mkr 135.95M
Operating Expense
kr 325.51Mkr 292.50Mkr 207.02Mkr 173.92Mkr 158.84Mkr 122.47M
Operating Income
kr 11.04Mkr 4.46Mkr -18.74Mkr -44.19Mkr 3.97Mkr 13.48M
Net Non Operating Interest Income Expense
kr 4.82Mkr 1.03Mkr 19.47Mkr -482.00Kkr 120.00Kkr 235.00K
Other Income Expense
------
Pretax Income
kr 32.69Mkr 22.31Mkr 6.67Mkr -57.26Mkr 5.29Mkr 17.50M
Tax Provision
kr 4.85Mkr 3.89Mkr -1.49Mkr -13.53Mkr 351.00Kkr 4.81M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 27.84Mkr 18.43Mkr 8.15Mkr -43.73Mkr 4.94Mkr 12.69M
Basic EPS
kr 0.94kr 0.62kr 0.28kr -1.61kr 0.19kr 0.48
Diluted EPS
kr 0.94kr 0.62kr 0.28kr -1.61kr 0.18kr 0.48
Basic Average Shares
kr 118.44Mkr 29.53Mkr 28.85Mkr 27.17Mkr 26.52Mkr 26.30M
Diluted Average Shares
kr 118.44Mkr 29.53Mkr 28.94Mkr 27.35Mkr 26.80Mkr 26.30M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 452.21Mkr 410.84Mkr 277.13Mkr 224.05Mkr 216.87Mkr 174.39M
Net Income From Continuing And Discontinued Operation
kr 27.84Mkr 18.43Mkr 8.15Mkr -43.73Mkr 4.94Mkr 12.69M
Normalized Income
kr 27.84Mkr 18.64Mkr 8.18Mkr -43.73Mkr 4.99Mkr 12.69M
Interest Expense
-kr 605.00Kkr 276.00Kkr 361.00Kkr 285.00Kkr 128.00K
EBIT
kr 29.50Mkr 22.92Mkr 6.94Mkr -56.90Mkr 5.58Mkr 17.63M
EBITDA
kr 29.50Mkr 65.09Mkr 39.20Mkr -26.86Mkr 30.43Mkr 34.55M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis